Systemic complications of acromegaly and the impact of the current treatment landscape: an update

MR Gadelha, L Kasuki, DST Lim… - Endocrine reviews, 2019 - academic.oup.com
Acromegaly is a chronic systemic disease with many complications and is associated with
increased mortality when not adequately treated. Substantial advances in acromegaly …

Growth hormone's links to cancer

CL Boguszewski, MCS Boguszewski - Endocrine reviews, 2019 - academic.oup.com
Several components of the GH axis are involved in tumor progression, and GH-induced
intracellular signaling has been strongly associated with breast cancer susceptibility in …

Mice with gene alterations in the GH and IGF family

Y Qian, DE Berryman, R Basu, EO List, S Okada… - Pituitary, 2022 - Springer
Much of our understanding of GH's action stems from animal models and the generation and
characterization of genetically altered or modified mice. Manipulation of genes in the …

Blockade of growth hormone receptor signaling by using pegvisomant: a functional therapeutic strategy in hepatocellular carcinoma

AO Kaseb, A Haque, D Vishwamitra… - Frontiers in …, 2022 - frontiersin.org
Hepatocellular carcinoma (HCC) is an aggressive neoplasm with poor clinical outcome
because most patients present at an advanced stage, at which point curative surgical …

Tumour-derived human growth hormone as a therapeutic target in oncology

JK Perry, ZS Wu, HC Mertani, T Zhu… - Trends in Endocrinology & …, 2017 - cell.com
The growth hormone (GH) and insulin-like growth factor-1 (IGF1) axis is the key regulator of
longitudinal growth, promoting postnatal bone and muscle growth. The available data …

[HTML][HTML] Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular …

MAA El-Makarem, MF Kamel, AA Mohamed, HA Ali… - Plos one, 2022 - ncbi.nlm.nih.gov
Results Compared with cirrhotic patients without HCC and healthy controls, cirrhotic patients
with HCC had significantly lower hepatic expression of GHR, STAT5, and IGF-1proteins …

Growth hormone in the tumor microenvironment

V Chesnokova, S Melmed - Archives of Endocrinology and …, 2019 - SciELO Brasil
Tumor development is a multistep process whereby local mechanisms enable somatic
mutations during preneoplastic stages. Once a tumor develops, it becomes a complex organ …

Novel adamantanyl-based thiadiazolyl pyrazoles targeting EGFR in triple-negative breast cancer

A Sebastian, V Pandey, CD Mohan, YT Chia… - ACS …, 2016 - ACS Publications
The epidermal growth factor receptor (EGFR) is a validated therapeutic target for triple-
negative breast cancer (TNBC). In the present study, we synthesize novel adamantanyl …

[HTML][HTML] The effects of growth hormone on therapy resistance in cancer

R Basu, JJ Kopchick - Cancer Drug Resistance, 2019 - ncbi.nlm.nih.gov
Pituitary derived and peripherally produced growth hormone (GH) is a crucial mediator of
longitudinal growth, organ development, metabolic regulation with tissue specific, sex …

Disruption of growth hormone receptor signaling abrogates hepatocellular carcinoma development

A Haque, V Sahu, JL Lombardo, L Xiao… - Journal of …, 2022 - Taylor & Francis
Introduction Hepatocellular carcinoma (HCC) is the most common type of primary liver
cancers. It is an aggressive neoplasm with dismal outcome because most of the patients …